NCT05484167View on ClinicalTrials.gov

Natesto Testosterone Nasal Gel for Hypogonadal Men

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

April 1, 2025

Conditions
Erectile DysfunctionSexual Dysfunction
Interventions
DRUG

Natesto Nasal Product

Nasal Gel used for 90 days then crossed over to placebo gel

DRUG

Placebo

A nasal gel with no active ingredients

Trial Locations (1)

84132

University of Utah, Division of Urology, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

Acerus Pharmaceuticals Corporation

INDUSTRY

lead

University of Utah

OTHER